-
Parkway Life REIT (SGX:C2PU) is one of Asia’s largest listed healthcare REITs by asset size offering highly visible and stable earnings. This is by virtue of its resilient industry and long leases with downside risk protection.
- - Read this at SGinvestors.io -
A new lease of life with rental upside till 2042.
-
Parkway Life REIT will see the long-anticipated uplift in distributions following the renewal of the master lease for Singapore hospitals in 2021 and roll-off of rent rebates in FY25, with close to 20% y-o-y growth in DPU expected in FY26.
- - Read this at SGinvestors.io -
Time to execute on acquisitions and AEIs.
- Read more at SGinvestors.io.
Above is an excerpt from a report by DBS Group Research.
Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.
Tabitha Foo DBS Group Research | Derek Tan DBS Group Research | Geraldine WONG DBS Group Research | https://www.dbs.com/insightsdirect/ 2026-07-13
Previous report by DBS:
2026-05-22 Parkway Life REIT - A DPU Compounder In The Making.
Price targets by 3 other brokers at Parkway Life REIT Target Prices.
Listing of research reports at Parkway Life REIT Analyst Reports.
Relevant links:
Parkway Life REIT Share Price History,
Parkway Life REIT Announcements,
Parkway Life REIT Dividend Payout Dates & Corporate Actions,
Parkway Life REIT News
